Related Experiment Video
Updated: Dec 31, 2025

07:09
Use of a High-throughput In Vitro Microfluidic System to Develop Oral Multi-species Biofilms
Published on: December 1, 2014
13.9K
Recent progress in experimental and human disease-associated multi-species biofilms
Fang Bai1, Zhao Cai2, Liang Yang3
1State Key Laboratory of Medicinal Chemical Biology, Key Laboratory of Molecular Microbiology and Technology of the Ministry of Education, Department of Microbiology, College of Life Sciences, Nankai University, Tianjin, China.
Computational and Structural Biotechnology Journal
|January 11, 2020
Summary
Human microbiota, comprising trillions of microbes, impacts health. This review explores multi-species biofilms, suggesting biofilm engineering could manipulate microbiota composition and function for disease treatment.
Area of Science:
- Microbiology
- Human Health
- Biofilm Research
Background:
- The human body hosts trillions of microorganisms, collectively known as the human microbiota, crucial for health.
- Next-generation sequencing links microbiota genetics to human diseases, but spatial organization and interactions remain unclear.
- Microbial communities often form surface-attached biofilms, facilitating intercellular communication and ecosystem dynamics.
Purpose of the Study:
- To review recent advancements in experimental and disease-associated multi-species biofilm studies.
- To explore the potential of biofilm engineering for modulating human microbiota composition and function.
Main Methods:
- Literature review of experimental biofilm studies.
- Analysis of human disease-associated multi-species biofilm research.
Main Results:
- Summarizes current understanding of multi-species biofilms in various environments.
- Highlights the role of biofilms in microbial interactions and communication.
- Identifies gaps in knowledge regarding microbiota spatial organization.
Conclusions:
- Biofilms are critical structures for microbial communities.
- Engineering biofilm structures and interspecies interactions presents a novel therapeutic strategy.
- Potential to manipulate human microbiota for treating diseases associated with microbial dysbiosis.

